These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30798787)

  • 1. Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure.
    Kurtovic L; Agius PA; Feng G; Drew DR; Ubillos I; Sacarlal J; Aponte JJ; Fowkes FJI; Dobaño C; Beeson JG
    BMC Med; 2019 Feb; 17(1):45. PubMed ID: 30798787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children.
    Ubillos I; Ayestaran A; Nhabomba AJ; Dosoo D; Vidal M; Jiménez A; Jairoce C; Sanz H; Aguilar R; Williams NA; Díez-Padrisa N; Mpina M; Sorgho H; Agnandji ST; Kariuki S; Mordmüller B; Daubenberger C; Asante KP; Owusu-Agyei S; Sacarlal J; Aide P; Aponte JJ; Dutta S; Gyan B; Campo JJ; Valim C; Moncunill G; Dobaño C
    BMC Med; 2018 Oct; 16(1):197. PubMed ID: 30376866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children.
    Feng G; Kurtovic L; Agius PA; Aitken EH; Sacarlal J; Wines BD; Hogarth PM; Rogerson SJ; Fowkes FJI; Dobaño C; Beeson JG
    BMC Med; 2022 Aug; 20(1):289. PubMed ID: 36002841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children.
    Mugo RM; Mwai K; Mwacharo J; Shee FM; Musyoki JN; Wambua J; Otieno E; Bejon P; Ndungu FM
    Malar J; 2021 Dec; 20(1):452. PubMed ID: 34856981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody mechanisms of protection against malaria in RTS,S-vaccinated children: a post-hoc serological analysis of phase 2 trial.
    Kurtovic L; Feng G; Hysa A; Haghiri A; O'Flaherty K; Wines BD; Santano R; D'Andrea L; Drummer HE; Hogarth PM; Sacarlal J; Fowkes FJI; Simpson JA; Dobaño C; Beeson JG
    Lancet Microbe; 2024 Oct; 5(10):100898. PubMed ID: 39127054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity.
    Kurtovic L; Drew DR; Dent AE; Kazura JW; Beeson JG
    Front Immunol; 2021; 12():775659. PubMed ID: 34925347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional Antibodies Are Induced by the RTS,S Malaria Vaccine and Associated With Protection in a Phase 1/2a Trial.
    Kurtovic L; Atre T; Feng G; Wines BD; Chan JA; Boyle MJ; Drew DR; Hogarth PM; Fowkes FJI; Bergmann-Leitner ES; Beeson JG
    J Infect Dis; 2021 Oct; 224(7):1128-1138. PubMed ID: 32236404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.
    Dobaño C; Ubillos I; Jairoce C; Gyan B; Vidal M; Jiménez A; Santano R; Dosoo D; Nhabomba AJ; Ayestaran A; Aguilar R; Williams NA; Díez-Padrisa N; Lanar D; Chauhan V; Chitnis C; Dutta S; Gaur D; Angov E; Asante KP; Owusu-Agyei S; Valim C; Gamain B; Coppel RL; Cavanagh D; Beeson JG; Campo JJ; Moncunill G
    BMC Med; 2019 Aug; 17(1):157. PubMed ID: 31409398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Patterns of IgG Subclass Responses to
    Dobaño C; Santano R; Vidal M; Jiménez A; Jairoce C; Ubillos I; Dosoo D; Aguilar R; Williams NA; Díez-Padrisa N; Ayestaran A; Valim C; Asante KP; Owusu-Agyei S; Lanar D; Chauhan V; Chitnis C; Dutta S; Angov E; Gamain B; Coppel RL; Beeson JG; Reiling L; Gaur D; Cavanagh D; Gyan B; Nhabomba AJ; Campo JJ; Moncunill G
    Front Immunol; 2019; 10():439. PubMed ID: 30930896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RTS,S/AS01
    Suau R; Vidal M; Aguilar R; Ruiz-Olalla G; Vázquez-Santiago M; Jairoce C; Nhabomba AJ; Gyan B; Dosoo D; Asante KP; Owusu-Agyei S; Campo JJ; Izquierdo L; Cavanagh D; Coppel RL; Chauhan V; Angov E; Dutta S; Gaur D; Beeson JG; Moncunill G; Dobaño C
    Vaccine; 2021 Jan; 39(4):687-698. PubMed ID: 33358704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.
    Zenklusen I; Jongo S; Abdulla S; Ramadhani K; Lee Sim BK; Cardamone H; Flannery EL; Nguyen T; Fishbaugher M; Steel RWJ; Betz W; Carmago N; Mikolajczak S; Kappe SHI; Hoffman SL; Sack BK; Daubenberger C
    J Infect Dis; 2018 Apr; 217(10):1569-1578. PubMed ID: 29438525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity.
    Chaudhury S; Ockenhouse CF; Regules JA; Dutta S; Wallqvist A; Jongert E; Waters NC; Lemiale F; Bergmann-Leitner E
    Malar J; 2016 May; 15():301. PubMed ID: 27245446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique.
    Campo JJ; Sacarlal J; Aponte JJ; Aide P; Nhabomba AJ; Dobaño C; Alonso PL
    Vaccine; 2014 Apr; 32(19):2209-16. PubMed ID: 24631081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children.
    Kurtovic L; Behet MC; Feng G; Reiling L; Chelimo K; Dent AE; Mueller I; Kazura JW; Sauerwein RW; Fowkes FJI; Beeson JG
    BMC Med; 2018 Apr; 16(1):61. PubMed ID: 29706136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum.
    Radin K; Clement F; Jongert E; Sterckx YG; Ockenhouse C; Regules J; Lemiale F; Leroux-Roels G
    Malar J; 2016 Nov; 15(1):543. PubMed ID: 27825382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial.
    White MT; Verity R; Griffin JT; Asante KP; Owusu-Agyei S; Greenwood B; Drakeley C; Gesase S; Lusingu J; Ansong D; Adjei S; Agbenyega T; Ogutu B; Otieno L; Otieno W; Agnandji ST; Lell B; Kremsner P; Hoffman I; Martinson F; Kamthunzu P; Tinto H; Valea I; Sorgho H; Oneko M; Otieno K; Hamel MJ; Salim N; Mtoro A; Abdulla S; Aide P; Sacarlal J; Aponte JJ; Njuguna P; Marsh K; Bejon P; Riley EM; Ghani AC
    Lancet Infect Dis; 2015 Dec; 15(12):1450-8. PubMed ID: 26342424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.
    Kester KE; Cummings JF; Ofori-Anyinam O; Ockenhouse CF; Krzych U; Moris P; Schwenk R; Nielsen RA; Debebe Z; Pinelis E; Juompan L; Williams J; Dowler M; Stewart VA; Wirtz RA; Dubois MC; Lievens M; Cohen J; Ballou WR; Heppner DG;
    J Infect Dis; 2009 Aug; 200(3):337-46. PubMed ID: 19569965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses to the RTS,S/AS01
    Sanchez L; Vidal M; Jairoce C; Aguilar R; Ubillos I; Cuamba I; Nhabomba AJ; Williams NA; Díez-Padrisa N; Cavanagh D; Angov E; Coppel RL; Gaur D; Beeson JG; Dutta S; Aide P; Campo JJ; Moncunill G; Dobaño C
    NPJ Vaccines; 2020; 5():46. PubMed ID: 32550014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children.
    Bojang KA; Olodude F; Pinder M; Ofori-Anyinam O; Vigneron L; Fitzpatrick S; Njie F; Kassanga A; Leach A; Milman J; Rabinovich R; McAdam KP; Kester KE; Heppner DG; Cohen JD; Tornieporth N; Milligan PJ
    Vaccine; 2005 Jul; 23(32):4148-57. PubMed ID: 15964483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.
    Walsh DS; Gettayacamin M; Leitner WW; Lyon JA; Stewart VA; Marit G; Pichyangkul S; Gosi P; Tongtawe P; Kester KE; Holland CA; Kolodny N; Cohen J; Voss G; Ballou WR; Heppner DG
    Vaccine; 2006 May; 24(19):4167-78. PubMed ID: 16574282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.